{"entity":{"type":"insider","cik":"0001465278","url":"/insider/0001465278","json_url":"/insider/0001465278.json","name":"Hagan Joseph P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":36,"n_filings":29,"first":"2012-06-29","last":"2025-01-31","span_basis":"filed_date"},"name_variants":[{"name":"Hagan Joseph P","source":"filing","n_filings":29,"first_seen":"2012-06-29","last_seen":"2025-01-31"}],"transactions":[{"id":4027187,"accession":"0000950170-25-011853","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-011853","line_url":"/filing/0000950170-25-011853#line-1","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":1.0852,"price_display":"1.09","price_state":"stated","total_value":54260.0,"total_display":"54,260.00","total_whole":"54,260","shares_owned_after":260808.0,"shares_owned_after_display":"260,808","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-30","filed_date":"2025-01-31","scope":"insider"},{"id":4311236,"accession":"0000950170-25-005883","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-005883","line_url":"/filing/0000950170-25-005883#line-2","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11764.0,"shares_display":"11,764","price_per_share":1.2632,"price_display":"1.26","price_state":"stated","total_value":14860.2848,"total_display":"14,860.28","total_whole":"14,860","shares_owned_after":210808.0,"shares_owned_after_display":"210,808","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-14","filed_date":"2025-01-15","scope":"insider"},{"id":4311230,"accession":"0000950170-25-005883","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-005883","line_url":"/filing/0000950170-25-005883#line-1","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":115290.0,"shares_display":"115,290","price_per_share":1.2632,"price_display":"1.26","price_state":"stated","total_value":145634.328,"total_display":"145,634.33","total_whole":"145,634","shares_owned_after":222572.0,"shares_owned_after_display":"222,572","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-13","filed_date":"2025-01-15","scope":"insider"},{"id":2697957,"accession":"0001209191-24-001873","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-001873","line_url":"/filing/0001209191-24-001873#line-1","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14580.0,"shares_display":"14,580","price_per_share":1.1906,"price_display":"1.19","price_state":"stated","total_value":17358.948,"total_display":"17,358.95","total_whole":"17,359","shares_owned_after":57112.0,"shares_owned_after_display":"57,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-18","filed_date":"2024-01-18","scope":"insider"},{"id":8451436,"accession":"0001600620-23-000021","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001600620-23-000021","line_url":"/filing/0001600620-23-000021#line-2","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":272.0,"shares_display":"272","price_per_share":10.58,"price_display":"10.58","price_state":"stated","total_value":2877.76,"total_display":"2,877.76","total_whole":"2,878","shares_owned_after":11961.0,"shares_owned_after_display":"11,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-19","filed_date":"2023-05-23","scope":"insider"},{"id":6651292,"accession":"0001209191-22-005061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-005061","line_url":"/filing/0001209191-22-005061#line-1","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.2152,"price_display":"0.22","price_state":"stated","total_value":21520.0,"total_display":"21,520.00","total_whole":"21,520","shares_owned_after":417006.0,"shares_owned_after_display":"417,006","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-26","filed_date":"2022-01-26","scope":"insider"},{"id":6161870,"accession":"0001628280-22-000182","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-22-000182","line_url":"/filing/0001628280-22-000182","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":22.5912535,"price_display":"22.59","price_state":"stated","total_value":903650.14,"total_display":"903,650.14","total_whole":"903,650","shares_owned_after":4134.0,"shares_owned_after_display":"4,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-04","scope":"insider","n_lines":2},{"id":4226748,"accession":"0001209191-21-033297","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-033297","line_url":"/filing/0001209191-21-033297#line-1","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4186.0,"shares_display":"4,186","price_per_share":0.89,"price_display":"0.89","price_state":"stated","total_value":3725.54,"total_display":"3,725.54","total_whole":"3,726","shares_owned_after":316292.0,"shares_owned_after_display":"316,292","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-17","filed_date":"2021-05-17","scope":"insider"},{"id":9271497,"accession":"0001209191-21-026951","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-026951","line_url":"/filing/0001209191-21-026951#line-1","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4144.0,"shares_display":"4,144","price_per_share":1.72,"price_display":"1.72","price_state":"stated","total_value":7127.68,"total_display":"7,127.68","total_whole":"7,128","shares_owned_after":244628.0,"shares_owned_after_display":"244,628","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-04-16","scope":"insider"},{"id":4222927,"accession":"0001209191-21-011377","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-011377","line_url":"/filing/0001209191-21-011377#line-1","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4144.0,"shares_display":"4,144","price_per_share":1.72,"price_display":"1.72","price_state":"stated","total_value":7127.68,"total_display":"7,127.68","total_whole":"7,128","shares_owned_after":485756.0,"shares_owned_after_display":"485,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-17","scope":"insider"},{"id":2146231,"accession":"0001209191-20-059050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-059050","line_url":"/filing/0001209191-20-059050#line-1","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6094.0,"shares_display":"6,094","price_per_share":0.5211,"price_display":"0.52","price_state":"stated","total_value":3175.5834,"total_display":"3,175.58","total_whole":"3,176","shares_owned_after":215994.0,"shares_owned_after_display":"215,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-16","filed_date":"2020-11-18","scope":"insider"},{"id":3090671,"accession":"0001209191-20-047033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-047033","line_url":"/filing/0001209191-20-047033#line-1","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4245.0,"shares_display":"4,245","price_per_share":0.6049,"price_display":"0.60","price_state":"stated","total_value":2567.8005,"total_display":"2,567.80","total_whole":"2,568","shares_owned_after":222088.0,"shares_owned_after_display":"222,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-14","filed_date":"2020-08-17","scope":"insider"},{"id":2682405,"accession":"0001209191-20-030089","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-030089","line_url":"/filing/0001209191-20-030089#line-1","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4426.0,"shares_display":"4,426","price_per_share":0.6267,"price_display":"0.63","price_state":"stated","total_value":2773.7742,"total_display":"2,773.77","total_whole":"2,774","shares_owned_after":226333.0,"shares_owned_after_display":"226,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-15","filed_date":"2020-05-18","scope":"insider"},{"id":2529475,"accession":"0001209191-20-010754","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-010754","line_url":"/filing/0001209191-20-010754#line-1","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4324.0,"shares_display":"4,324","price_per_share":0.8304,"price_display":"0.83","price_state":"stated","total_value":3590.6496,"total_display":"3,590.65","total_whole":"3,591","shares_owned_after":230759.0,"shares_owned_after_display":"230,759","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-18","filed_date":"2020-02-19","scope":"insider"},{"id":2709324,"accession":"0001209191-20-000785","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-000785","line_url":"/filing/0001209191-20-000785#line-1","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8345.0,"shares_display":"8,345","price_per_share":0.9667,"price_display":"0.97","price_state":"stated","total_value":8067.1115,"total_display":"8,067.11","total_whole":"8,067","shares_owned_after":235083.0,"shares_owned_after_display":"235,083","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-03","scope":"insider"},{"id":7928872,"accession":"0001209191-19-056799","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-056799","line_url":"/filing/0001209191-19-056799#line-1","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5838.0,"shares_display":"5,838","price_per_share":0.64,"price_display":"0.64","price_state":"stated","total_value":3736.32,"total_display":"3,736.32","total_whole":"3,736","shares_owned_after":243428.0,"shares_owned_after_display":"243,428","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-14","filed_date":"2019-11-15","scope":"insider"},{"id":8677464,"accession":"0001209191-19-051910","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-051910","line_url":"/filing/0001209191-19-051910#line-1","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8743.0,"shares_display":"8,743","price_per_share":0.6827,"price_display":"0.68","price_state":"stated","total_value":5968.8461,"total_display":"5,968.85","total_whole":"5,969","shares_owned_after":249266.0,"shares_owned_after_display":"249,266","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-01","filed_date":"2019-10-02","scope":"insider"},{"id":8418641,"accession":"0001209191-19-046314","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-046314","line_url":"/filing/0001209191-19-046314#line-1","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4375.0,"shares_display":"4,375","price_per_share":0.5506,"price_display":"0.55","price_state":"stated","total_value":2408.875,"total_display":"2,408.88","total_whole":"2,409","shares_owned_after":258009.0,"shares_owned_after_display":"258,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-15","filed_date":"2019-08-16","scope":"insider"},{"id":7841211,"accession":"0001209191-19-040504","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-040504","line_url":"/filing/0001209191-19-040504#line-1","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5783.0,"shares_display":"5,783","price_per_share":1.3115,"price_display":"1.31","price_state":"stated","total_value":7584.4045,"total_display":"7,584.40","total_whole":"7,584","shares_owned_after":262384.0,"shares_owned_after_display":"262,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-01","filed_date":"2019-07-02","scope":"insider"},{"id":8026750,"accession":"0001209191-19-030512","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-030512","line_url":"/filing/0001209191-19-030512#line-2","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39352.0,"shares_display":"39,352","price_per_share":1.2189,"price_display":"1.22","price_state":"stated","total_value":47966.1528,"total_display":"47,966.15","total_whole":"47,966","shares_owned_after":268167.0,"shares_owned_after_display":"268,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-16","filed_date":"2019-05-16","scope":"insider"},{"id":8345316,"accession":"0001209191-19-028281","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-028281","line_url":"/filing/0001209191-19-028281#line-1","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33194.0,"shares_display":"33,194","price_per_share":1.08,"price_display":"1.08","price_state":"stated","total_value":35849.52,"total_display":"35,849.52","total_whole":"35,850","shares_owned_after":64542.0,"shares_owned_after_display":"64,542","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-07","filed_date":"2019-05-08","scope":"insider"},{"id":8065408,"accession":"0001209191-19-023136","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-023136","line_url":"/filing/0001209191-19-023136#line-1","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5842.0,"shares_display":"5,842","price_per_share":0.981,"price_display":"0.98","price_state":"stated","total_value":5731.002,"total_display":"5,731.00","total_whole":"5,731","shares_owned_after":31348.0,"shares_owned_after_display":"31,348","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-01","filed_date":"2019-04-03","scope":"insider"},{"id":4358970,"accession":"0001209191-17-046233","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-046233","line_url":"/filing/0001209191-17-046233#line-1","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":219780.0,"shares_display":"219,780","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":199999.8,"total_display":"199,999.80","total_whole":"200,000","shares_owned_after":241297.0,"shares_owned_after_display":"241,297","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-25","filed_date":"2017-07-25","scope":"insider"},{"id":2281029,"accession":"0001209191-16-106685","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-106685","line_url":"/filing/0001209191-16-106685#line-1","is_derivative":false,"issuer_cik":"0001465278","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001465278","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":7.19,"price_display":"7.19","price_state":"stated","total_value":71900.0,"total_display":"71,900.00","total_whole":"71,900","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-03","filed_date":"2016-03-07","scope":"insider"},{"id":7031646,"accession":"0001181431-14-031926","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-031926","line_url":"/filing/0001181431-14-031926#line-1","is_derivative":false,"issuer_cik":"0001382911","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001382911","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Officer (Sr. VP, Corporate Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Corporate Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Corporate Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.69,"price_display":"4.69","price_state":"stated","total_value":23450.0,"total_display":"23,450.00","total_whole":"23,450","shares_owned_after":13026.0,"shares_owned_after_display":"13,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-15","filed_date":"2014-09-15","scope":"insider"},{"id":4396177,"accession":"0001181431-13-042654","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-042654","line_url":"/filing/0001181431-13-042654#line-2","is_derivative":false,"issuer_cik":"0001382911","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001382911","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":7.8,"price_display":"7.80","price_state":"stated","total_value":93600.0,"total_display":"93,600.00","total_whole":"93,600","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-31","filed_date":"2013-08-02","scope":"insider"},{"id":5293168,"accession":"0001181431-13-041738","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-041738","line_url":"/filing/0001181431-13-041738#line-2","is_derivative":false,"issuer_cik":"0001382911","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001382911","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":7.4,"price_display":"7.40","price_state":"stated","total_value":74000.0,"total_display":"74,000.00","total_whole":"74,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-26","filed_date":"2013-07-29","scope":"insider"},{"id":5390627,"accession":"0001181431-13-031630","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-031630","line_url":"/filing/0001181431-13-031630#line-2","is_derivative":false,"issuer_cik":"0001382911","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001382911","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28000.0,"shares_display":"28,000","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":196000.0,"total_display":"196,000.00","total_whole":"196,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-28","filed_date":"2013-05-30","scope":"insider"},{"id":2892379,"accession":"0001181431-12-040672","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-12-040672","line_url":"/filing/0001181431-12-040672","is_derivative":false,"issuer_cik":"0001382911","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001382911","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":6.766666666666667,"price_display":"6.77","price_state":"stated","total_value":203000.0,"total_display":"203,000.00","total_whole":"203,000","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-13","filed_date":"2012-07-13","scope":"insider","n_lines":2},{"id":3389387,"accession":"0001181431-12-038584","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001181431-12-038584","line_url":"/filing/0001181431-12-038584#line-8","is_derivative":false,"issuer_cik":"0001382911","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001382911","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":6.3,"price_display":"6.30","price_state":"stated","total_value":75600.0,"total_display":"75,600.00","total_whole":"75,600","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-29","filed_date":"2012-06-29","scope":"insider"},{"id":3389385,"accession":"0001181431-12-038584","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-12-038584","line_url":"/filing/0001181431-12-038584#line-6","is_derivative":false,"issuer_cik":"0001382911","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001382911","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26000.0,"shares_display":"26,000","price_per_share":5.9,"price_display":"5.90","price_state":"stated","total_value":153400.0,"total_display":"153,400.00","total_whole":"153,400","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-28","filed_date":"2012-06-29","scope":"insider"},{"id":3389382,"accession":"0001181431-12-038584","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-12-038584","line_url":"/filing/0001181431-12-038584","is_derivative":false,"issuer_cik":"0001382911","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001382911","owner_cik":"0001465278","owner_name":"Hagan Joseph P","owner_display_name":"Hagan Joseph P","owner_url":"/insider/0001465278","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70000.0,"shares_display":"70,000","price_per_share":5.257142857142857,"price_display":"5.26","price_state":"stated","total_value":368000.0,"total_display":"368,000.00","total_whole":"368,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-27","filed_date":"2012-06-29","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":36,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":30,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":36},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001505512","name":"Regulus Therapeutics Inc.","url":"/issuer/0001505512","role":"Director, Officer (Chief Executive Officer)","n_filings":21,"first_seen":"2016-03-07","last_seen":"2025-01-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001600620","name":"Aurinia Pharmaceuticals Inc.","url":"/issuer/0001600620","role":"Director","n_filings":2,"first_seen":"2022-01-04","last_seen":"2023-05-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001382911","name":"Orexigen Therapeutics, Inc.","url":"/issuer/0001382911","role":"Officer (Sr. VP, Corporate Development)","n_filings":6,"first_seen":"2012-06-29","last_seen":"2014-09-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001465278","retrieved_at":"2026-08-24T12:40:27+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}